|
SIK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.24440000000148E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.20710000001334E-06 |
| Normal-vs-Stage2 |
2.897500E-03 |
| Normal-vs-Stage3 |
8.1839000000028E-05 |
| Normal-vs-Stage4 |
2.85349999962214E-07 |
| Stage1-vs-Stage2 |
9.482200E-01 |
| Stage1-vs-Stage3 |
4.724000E-01 |
| Stage1-vs-Stage4 |
2.484500E-03 |
| Stage2-vs-Stage3 |
5.094800E-01 |
| Stage2-vs-Stage4 |
4.065600E-02 |
| Stage3-vs-Stage4 |
9.895800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75709999947505E-07 |
| Normal-vs-AfricanAmerican |
6.06429999999714E-05 |
| Normal-vs-Asian |
2.36939999999075E-05 |
| Caucasian-vs-AfricanAmerican |
4.585800E-01 |
| Caucasian-vs-Asian |
1.443410E-01 |
| AfricanAmerican-vs-Asian |
1.302420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99605999999797E-05 |
| Normal-vs-Female |
1.010170E-02 |
| Male-vs-Female |
1.139680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.9865999999964E-05 |
| Normal-vs-Extreme_Weight |
4.55470000004787E-06 |
| Normal-vs-Obese |
6.162100E-04 |
| Normal-vs-Extreme_Obese |
1.437950E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.851800E-01 |
| Normal_Weight-vs-Obese |
1.715790E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.481800E-01 |
| Extreme_Weight-vs-Obese |
1.632380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.025200E-01 |
| Obese-vs-Extreme_Obese |
2.360600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.392900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.801500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.62427999998993E-05 |
| Normal-vs-Age(81-100Yrs) |
9.397100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.122200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.071000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.498600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.092440E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.075200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.130200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.93320000000585E-05 |
| Normal-VS-Type2 PRCC |
1.224050E-04 |
| Normal-VS-KIRP CIMP |
1.938100E-03 |
| Normal-VS-Unclassified PRCC |
9.319300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.664800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.218200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.007770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.854200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.735160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.567800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76158999999343E-05 |
| Normal-vs-N1 |
2.32699999999086E-05 |
| Normal-vs-N2 |
1.017440E-01 |
| N0-vs-N1 |
9.741400E-01 |
| N0-vs-N2 |
7.483800E-01 |
| N1-vs-N2 |
7.060000E-01 |
|
|
